Udo Rudloff

11PUBLICATIONS
82CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 12, 2025
Emerging therapeutics targeting tumor-associated macrophages for the treatment of solid organ cancers.

Dandan Li, Udo Rudloff

|Aug 30, 2024
Fatty Acid Derivatization and Cyclization of the Immunomodulatory Peptide RP-182 Targeting CD206high Macrophages Improve Antitumor Activity.

Sitanshu S Singh, Raul Calvo, Anju Kumari

|Feb 15, 2023
Scaffolding Protein Connector Enhancer of Kinase Suppressor of Ras 1 (CNKSR1) Regulates MAPK Inhibition Responsiveness in Pancreas Cancer via Crosstalk with AKT Signaling.

Dandan Li, Anne M Miermont, Rushikesh Sable

|Aug 11, 2021
T Cell-Mediated Antitumor Immunity Cooperatively Induced By TGFβR1 Antagonism and Gemcitabine Counteracts Reformation of the Stromal Barrier in Pancreatic Cancer.

Dandan Li, Nicholas Schaub, Theresa M Guerin

|Jan 06, 2021
Phase II study of selumetinib, an orally active inhibitor of MEK1 and MEK2 kinases, in KRASG12R-mutant pancreatic ductal adenocarcinoma.

Cara Kenney, Tricia Kunst, Santhana Webb

|Mar 19, 2020
Metabolism and pharmacokinetics characterization of metarrestin in multiple species.

Elias C Padilha, Pranav Shah, Amy Q Wang

Pageof 2

Frequent Collaborators

4 joint publications

Juan Marugan

3 joint publications

Bolormaa Baljinnyam

3 joint publications

Yongmei Zhao

3 joint publications

Zachary Knotts